Price T Rowe Associates Inc Sorrento Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.74 - $1.83 $11,973 - $29,611	16,181 Added 8.37%	209,418 $186,000
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $78,030 - $148,826	51,676 Added 36.5%	193,237 $304,000
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $13,449 - $25,271	10,846 Added 8.3%	141,561 $285,000
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $37,618 - $92,164	18,809 Added 16.81%	130,715 $305,000
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.23 $46,188 - $71,815	9,933 Added 9.74%	111,906 $520,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $166,725 - $247,275	-22,500 Reduced 18.08%	101,973 $778,000
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $88,830 - $139,890	13,989 Added 12.66%	124,473 $1.21 Million
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $55,473 - $130,280	-7,891 Reduced 6.67%	110,484 $914,000
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $681,840 - $1.41 Million	118,375 New	118,375 $808,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.